FDA Grants Priority Review to Sarclisa for Multiple Myeloma

2 years ago 83

Sarclisa was granted a priority review by the Food and Drug Administration for patients newly diagnosed with multiple myeloma who are ineligible for blood transplants.

View Entire Post

Read Entire Article
  1. Homepage
  2. Coupons
  3. FDA Grants Priority Review to Sarclisa for Multiple Myeloma

Related

Trending

1. John Fetterman
2. Karen Read
3. Florida Panthers
4. Georgia baseball
5. Malawi
6. Tony Evans
7. Rebecca Grossman
8. iOS 18 beta
9. Maren Morris
10. Nvidia stock price

Popular

WELCOME
just now

'Changing of the Guard'? AMD, Intel, and Micron Soar While Nvidia Lags
4 days ago

The Tim Ferriss Show Transcripts: Elad Gil, Consigliere to Empire Builders — How to Spot Billion-Dollar Companies Before Everyone Else, The Misty AI Frontier, How Coke Beat Pepsi, When Consensus Pays, and Much More (#863)
2 weeks ago

Sources: Meta is building agentic tools, including an OpenClaw-like assistant powered by its new Muse Spark AI model to help users create AI bots (Hannah Murphy/Financial Times)
a week ago

Google Meet now lets you choose what’s included in your meeting notes
2 weeks ago

Former Nintendo Executive Says Amazon Once Requested 'Illegal' Price Discounts
2 weeks ago
© Obiaks 2024. All rights are reserved